ASEAN Heart Journal

First online: 

Case Reports

Thought Leadership on Thrombotic Disorders in South East Asia

Mark Y. Chan

21 May 2014

April 2014, 22:4

Case Reports

  • Facebook Social Icon
  • Twitter Social Icon
  • Google+ Social Icon

Reference Tools

References

1. http://www.who.int/mediacentre/factsheets/fs310/en/index.html (accessed 6-1-2014).

 

2. http://www.portola.com/Anticoagulant-Market (accessed 6-1-2014).

 

3. http://www.nrdo.gov.sg/uploadedFiles/NRDO/Publications/20110211%20AMI%20Information%20Paper%202010%20v3.pdf (accessed 6-1-2014).

 

4. http://www.moh.gov.sg/content/moh_web/home/costs_and_financing/HospitalBillSize.html (accessed 6-1-2014).

 

5. Cho Yeow Koh, Maria Kazimirova, Adama Trimnell, Peter Takac, Milan Labuda, Patricia A. Nuttall, and R. Manjunatha Kini: Variegin, a Novel Fast and Tight Binding Thrombin Inhibitor from the Tropical Bont Tick. Journal of Biological Chemistry, 282, 40, 29101–29113.

 

6. http://​www.​cardiosource.​org/​Science-And-Quality/​Clinical-Trials/​H/​HEAT-PPCI.​aspx (accessed 17-4-2014)

 

7. Tan Huay Cheem, Heparin has No Place as an Anticoagulant in PCI – A Protagonist’s View, ASEAN Heart Journal, Springer Global Science Journals, Vol.22, no.1, 14-18 (2014).

 

8. Kim Moo Hyun, Opposition: Unfractionated heparin should no longer be used in the catheterization laboratory, ASEAN Heart Journal, Springer Global Science Journals, Vol.22, no.1, 38-41 (2014).

 

9. Chee Yen Lin, New Oral Anticoagulants, ASEAN Heart Journal, Springer Global Science Journals, Vol.22, no.1, 30-37 (2014).

 

10. Alan Fong, Thrombin and FXa plasma concentration levels in patients with atrial fi brillation on long term warfarin therapy, ASEAN Heart Journal, Springer Global Science Journals, Vol.22, no.1, 20-29 (2014).

.

Tel No: +603-7931 7900
Fax No: +603-7932 1400

 

 

D-13A-06, Menara Suezcap 1, KL Gateway,
No.2 Jalan Kerinchi, Gerbang Kerinchi Lestari,
59200 Kuala Lumpur, Malaysia.

www.aseancardiology.org

ASEAN HEART Journal is Supported by Unrestricted Grant From 

Committed to therapeutic advances in cardiovascular research